The present proposal stems from our recent finding that initiated rats exposed for 13 months to orotic acid a pyrimidine nucleotide precursor developed 100% hepatocellular carcinoma with many metastases to lungs. Of the many mechanisms considered, creation of altered nucleotide pools that occurs following orotic acid feeding appears attractive because such an altered state can induce both genomic as well as membrane perturbations. Alterations at genomic and at membrane levels are considered to play important roles in tumorigenic process. In the present proposal experiments are designed to characterize the Orotic Acid Model in greater detail. For e.g. what is the minimum time of exposure to orotic acid required to develop hepatocellular carcinoma? Are the hyperplastic nodules developed in this model similar to those developed in other models? Can an imbalance of nucleotide pools caused by other means promote liver carcinogenesis? What types of genomic perturbations can be caused by an imbalance of nucleotides? Preliminary experiments carried out revealed that in addition to arotic acid feeding, thymine or thymidine also promoted the appearance of Gamma-glutamyl transferase positive foci induced by 1,2-dimethylhydrazine. In another preliminary experiment it was observed that one type of DNA damage caused by feeding arotic acid is the induction of alkali labile lesions. Some attractive features of this model are, orotic acid is a normal cellular constituent and present in the milk in considerable quantities. Increased orotic acid in milk, serum and urine occurs in some hereditary disorders and such and increase can also be achieved by creating several metabolic disturbances such as an essential amino acid deficiency and disturbances in urea cycle and unfortunately disturbances of this kind are not uncommon in human population at large.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA037077-03
Application #
3174750
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1984-04-01
Project End
1987-04-30
Budget Start
1986-04-01
Budget End
1987-04-30
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Toronto
Department
Type
DUNS #
259999779
City
Toronto
State
ON
Country
Canada
Zip Code
M5 1S8
Laconi, S; Curreli, F; Diana, S et al. (1999) Liver regeneration in response to partial hepatectomy in rats treated with retrorsine: a kinetic study. J Hepatol 31:1069-74
Manjeshwar, S; Rao, P M; Rajalakshmi, S et al. (1999) The regulation of ribonucleoside diphosphate reductase by the tumor promoter orotic acid in normal rat liver in vivo. Mol Carcinog 24:188-96
Tomasi, C; Laconi, E; Laconi, S et al. (1999) Effect of fasting/refeeding on the incidence of chemically induced hepatocellular carcinoma in the rat. Carcinogenesis 20:1979-83
Yusuf, A; Rao, P M; Rajalakshmi, S et al. (1999) Development of resistance during the early stages of experimental liver carcinogenesis. Carcinogenesis 20:1641-4
Yusuf, A; Laconi, E; Rao, P M et al. (1999) The effect of 1/3 partial hepatectomy on the growth of glutathione S-transferase positive foci. Carcinogenesis 20:1143-5
Vasudevan, S; Laconi, E; Rao, P M et al. (1998) Cycloheximide sensitivity of orotic acid biosynthesis induced by ammonia and glycine administration. Eur J Biochem 251:597-604
Laconi, E; Yusuf, A; Jahangir, A R et al. (1997) Transient inhibition by orotic acid does not abolish the in vivo response of rat hepatocytes to a direct mitogen, lead nitrate. J Hepatol 26:203-8
Laconi, E; Sarma, D S; Pani, P (1995) Transplantation of normal hepatocytes modulates the development of chronic liver lesions induced by a pyrrolizidine alkaloid, lasiocarpine. Carcinogenesis 16:139-42
Laconi, E; Tessitore, L; Milia, G et al. (1995) The enhancing effect of fasting/refeeding on the growth of nodules selectable by the resistant hepatocyte model in rat liver. Carcinogenesis 16:1865-9
Pascale, R M; Simile, M M; De Miglio, M R et al. (1995) Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid. Carcinogenesis 16:427-30

Showing the most recent 10 out of 48 publications